Selzentry (Maraviroc)

 

Selzentry (Maraviroc)

Selzentry (Maraviroc) is a prescription antiretroviral medication used to treat HIV-1 infection in adults and children aged 2 years and older. It works by blocking the CCR5 receptor on white blood cells, preventing HIV from entering and infecting them. Selzentry is typically taken in combination with other HIV medicines as part of a complete treatment plan to help lower viral load and maintain immune system health.

Why Choose Selzentry (Maraviroc)?

• Helps prevent HIV from entering immune cells.
• Reduces viral load when used with other HIV medications.
• Supports immune system strength and function.
• May improve CD4 cell counts over time.
• Available in tablet form for convenient oral use.

How to Use Selzentry (Maraviroc)?

• Take exactly as prescribed by your healthcare provider.
• Usually taken twice daily, with or without food.
• Do not change the dose or stop taking the medication without consulting your doctor.
• Swallow tablets whole, do not crush or chew.
• If you miss a dose, take it as soon as you remember unless it’s close to your next dose.
• Regularly monitor your liver function and viral load as advised by your healthcare provider.

Important Safety Information about Selzentry

• Not recommended for patients with severe kidney or liver impairment without medical supervision.
• Inform your doctor if you have hepatitis B or C, heart problems, or low blood pressure.
• May cause dizziness, avoid driving or operating machinery until you know how it affects you.
• Tell your healthcare provider about all medicines you take, including herbal supplements, as some may interact with Selzentry (e.g., certain antifungals, antibiotics, and antiretrovirals).
• Use only as part of a combination HIV therapy plan.

Fact Table

 

Facts	Details
Generic Name	Maraviroc
Brand Name	Selzentry
Drug Class	CCR5 Antagonist / Entry Inhibitor
Purpose	Used in combination with other antiretroviral agents to treat HIV-1 infection
Mechanism of Action	Blocks the CCR5 co-receptor on CD4 cells, preventing HIV-1 from entering and infecting the cells
Route of Administration	Oral
Use in Combination Therapy	Always used with other antiretroviral agents as part of combination HIV therapy
Onset of Action	Steady-state achieved within 7 days of consistent dosing
Contraindications	Hypersensitivity to Maraviroc; severe renal impairment (CrCl <30 mL/min) with concomitant potent CYP3A inhibitors/inducers
Precautions	Caution in patients with liver disease, low blood pressure, or heart disease
Common Side Effects	Cough, fever, rash, dizziness, abdominal pain, fatigue, muscle or joint pain
Drug Interactions	Strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin) and inducers (e.g., rifampin, carbamazepine) may alter Maraviroc levels
Monitoring Parameters	Liver function tests, renal function, blood pressure, CD4 count, HIV viral load
Storage Conditions	Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Prescription Status	Prescription only
Note	Selzentry is not a cure for HIV infection; adherence to combination therapy and safe practices remains essential

Common Side Effects

Like all medications, Selzentry (Maraviroc) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.

• Cough
• Fever
• Rash or skin irritation
• Stomach pain or bloating
• Dizziness or lightheadedness

If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.

How Can You Buy Selzentry (Maraviroc)?

You can order Selzentry (Maraviroc) using these methods on our website:

1. Order Online
2. Order by Phone
3. Order by Fax
4. Order your refills

Visit our How to order page.